1-3 of 3
Sophie De Guibert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of diagnostic investigations in the management of CAR T-cell–associated neurotoxicity

Clinical Trials & Observations
Matteo Mauget, Sophie Lemercier, Quentin Quelven, Adel Maamar, Faustine Lhomme, Sophie De Guibert, Roch Houot, Guillaume Manson
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2491–2498.
https://doi.org/10.1182/bloodadvances.2023011669
Published: 2024
Includes: Supplemental data
Journal Articles

A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial

Clinical Trials & Observations
Anne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier, Lydia Campos, Michel Ticchioni, Marie-Sarah Dilhuydy, Stephane Morisset, Valérie Rouille, Béatrice Mahé, Kamel Laribi, Bruno Villemagne, Emmanuelle Ferrant, Olivier Tournilhac, Alain Delmer, Lysiane Molina, Véronique Leblond, Cécile Tomowiak, Sophie de Guibert, Frederique Orsini-Piocelle, Anne Banos, Philippe Carassou, Guillaume Cartron, Luc Mathieu Fornecker, Loic Ysebaert, Caroline Dartigeas, Margot Truchan-Graczyk, Jean-Pierre Vilque, Thérèse Aurran Schleinitz, Florence Cymbalista, Stéphane Leprêtre, Vincent Lévy, Florence Nguyen-Khac, Pierre Feugier
Journal: Blood Advances
Blood Adv (2023) 7 (15): 3936–3945.
https://doi.org/10.1182/bloodadvances.2022009594
Published: 2023
Includes: Supplemental data
Journal Articles

Prolonged thrombocytopenia after CAR T-cell therapy: the role of thrombopoietin receptor agonists

Clinical Trials & Observations
Gaëlle Drillet, Faustine Lhomme, Sophie De Guibert, Guillaume Manson, Roch Houot
Journal: Blood Advances
Blood Adv (2023) 7 (4): 537–540.
https://doi.org/10.1182/bloodadvances.2022008066
Published: 2023
Includes: Supplemental data